Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New insights into the roles of antiapoptotic members of the Bcl-2 family in melanoma progression and therapy
Daniela Trisciuoglio, Donatella Del Bufalo
Drug Discovery Today (2021) Vol. 26, Iss. 5, pp. 1126-1135
Closed Access | Times Cited: 21

Showing 21 citing articles:

Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer
Arnab Sarkar, Abhik Paul, Tanmoy Banerjee, et al.
European Journal of Pharmacology (2023) Vol. 944, pp. 175588-175588
Closed Access | Times Cited: 29
Bcl-2 family inhibitors sensitize human cancer models to therapy
Elisabetta Valentini, Marta Di Martile, Matteo Brignone, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 14
Bcl-2 dependent modulation of Hippo pathway in cancer cells
Simona D’Aguanno, Matteo Brignone, Stefano Scalera, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Bcl-xL: A Focus on Melanoma Pathobiology
Anna Maria Lucianò, Ana B. Pérez‐Oliva, Víctoriano Mulero, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2777-2777
Open Access | Times Cited: 24
The inhibitory effect of 6-gingerol and cisplatin on ovarian cancer and antitumor activity: In silico, in vitro, and in vivo
Zohreh Salari, Ahmad Khosravi, Elham Pourkhandani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment
Anna Maria Lucianò, Marta Di Martile, Ana B. Pérez‐Oliva, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 7
BCL2 G quadruplex-binding small molecules: Current status and prospects for the development of next-generation anticancer therapeutics
Mamta Singh, Rajat Gupta, Lucia Comez, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 9, pp. 2551-2561
Closed Access | Times Cited: 10
Anti-proliferative activity of nitroquinolone fused acylhydrazones as non-small cell human lung cancer agents
Vandana Nandakumar, Sundarasamy Amsaveni, Kaviyarasu Adhigaman, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1331-1343
Closed Access | Times Cited: 5
Insights into the Role of Defective Apoptosis in Cancer Pathogenesis and Therapy
Sonia Thapa, Rafiq A. Rather, Shashank Singh, et al.
IntechOpen eBooks (2021)
Open Access | Times Cited: 9
The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme
Giovanni Gotte, Rachele Campagnari, Domenico Loreto, et al.
International Journal of Biological Macromolecules (2021) Vol. 191, pp. 560-571
Closed Access | Times Cited: 9
Bcl-2-like protein-10 increases aggressive features of melanoma cells
Donatella Del Bufalo, Marta Di Martile, Elisabetta Valentini, et al.
Exploration of Targeted Anti-tumor Therapy (2022), pp. 11-26
Open Access | Times Cited: 6
Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy
Xinyu Bai, Camelia Quek
Genes (2022) Vol. 13, Iss. 10, pp. 1757-1757
Open Access | Times Cited: 6
Comparative Expression Profiling Reveals Molecular Markers Involved in the Progression of Cutaneous Melanoma towards Metastasis
Andreea Daniela Lazăr, Sorina Dinescu, Lea Sleiman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6565-6565
Open Access | Times Cited: 3
Evaluation of Synthetic 2,4-Disubstituted-benzo[g]quinoxaline Derivatives as Potential Anticancer Agents
Islam Zaki, Sara A. Abu El-ata, Eman Fayad, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 853-853
Open Access | Times Cited: 7
Melanoma as Subsequent Primary Malignancy in Hematologic Cancer Survivors—A Literature Review
Salomea-Ruth Halmágyi, Loredana Ungureanu, Ioana-Irina Trufin, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4501-4501
Open Access
Picrasidine I Regulates Apoptosis in Melanoma Cell Lines by Activating ERK and JNK Pathways and Suppressing AKT Signaling
Mu‐Kuei Shieu, Chia‐Chieh Lin, Hsin‐Yu Ho, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 12, pp. 5309-5320
Open Access
Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma
Anum Jalil, Melissa M Donate, Jane Mattei
Cancer Drug Resistance (2024)
Open Access
Desenvolvimento de carreador lipídico nanoestruturado contendo pool de siRNAs associados a agente antitumoral como uma abordagem terapêutica multifuncional para o câncer de pele
Juliana Santos Rosa Viegas
(2022)
Open Access | Times Cited: 1
Bcl-2 family inhibitors sensitize human cancer models to target therapy
Elisabetta Valentini, Marta Di Martile, Matteo Brignone, et al.
Research Square (Research Square) (2023)
Open Access
Molecular mechanisms of tumor drug resistance
E.V. Okladnikova, Ivan Zinchenko, Т. Г. Рукша
Molekulyarnaya Meditsina (Molecular medicine) (2023) Vol. 21, Iss. 1, pp. 3-10
Closed Access
Empagliflozin induces apoptotic-signaling pathway in embryonic vasculature: In vivo and in silico approaches via chick’s yolk sac membrane model
Saeedeh Mosallanejad, Mehdi Mahmoodi, Hadi Tavakkoli, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access
Page 1

Scroll to top